Dr James Campbell, CEO, Patrys Ltd 00:00:00

Share On Facebook Share On Twitter

Patrys Ltd (ASX:PAB) CEO Dr James Campbell speaks with Andrew Scott from Proactive about new preclinical data for its full-sized IgG antibody, PAT-DX3 showing that it can cross the blood-brain barrier in healthy animals.

Recent Videos